These observations suggest that ADRB2 regulates downstream of FTO in the hippocampus to mediate depression-like behaviors and that ADRB2 may target SIRT1 through modulating the expression of c-MYC. The gene discussed is ADRB2; the disease is depressive symptom measurement.